Shammas, Masood A.
VA Boston Healthcare System,
United States
2025 Rank: 150467
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2666 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 150467 | 150027 |
| Total Cites | 264 | 293 |
| H-index | 7 | 8 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 75 | 75 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 94 | 96 |
| Number of Single+First+Last Authored Papers | 31 | 31 |
| Total Cites to Single+First+Last Authored Papers | 122 | 128 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 242 | 258 |
| Ratio of Total Citations to Distinct Citing Papers | 1.09 | 1.14 |
| Self-Citation Percentage |
9.90%
|
|
Shammas, Masood A.
Dana-Farber Cancer Institute,
United States
2023 Rank: 141090
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 5018 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 141090 | 152539 |
| Total Cites | 286 | 324 |
| H-index | 8 | 8 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 50 | 51 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 88 | 90 |
| Number of Single+First+Last Authored Papers | 29 | 29 |
| Total Cites to Single+First+Last Authored Papers | 102 | 109 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 258 | 279 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.16 |
| Self-Citation Percentage |
11.73%
|
|
Shammas, Masood A.
Dana-Farber Cancer Institute,
United States
2022 Rank: 107080
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 4020 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 107080 | 109813 |
| Total Cites | 321 | 372 |
| H-index | 8 | 9 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 67 | 67 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 99 | 102 |
| Number of Single+First+Last Authored Papers | 27 | 27 |
| Total Cites to Single+First+Last Authored Papers | 126 | 135 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 282 | 306 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.22 |
| Self-Citation Percentage |
13.71%
|
|
Shammas, Masood A.
Dana-Farber Cancer Institute,
United States
2021 Rank: 120368
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 4288 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 120368 | 123932 |
| Total Cites | 456 | 545 |
| H-index | 10 | 11 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 92 | 92 |
| Number of Single+First Authored Papers | 15 | 15 |
| Total Cites to Single+First Authored Papers | 132 | 135 |
| Number of Single+First+Last Authored Papers | 24 | 24 |
| Total Cites to Single+First+Last Authored Papers | 167 | 174 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 409 | 457 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.19 |
| Self-Citation Percentage |
16.33%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.